These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 38155239)
1. Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan. Yasuda K; Uchinami Y; Kano S; Taguchi J; Kawakita D; Kitayama M; Nishioka K; Mori T; Koizumi F; Fujii Y; Shimizu Y; Kobashi K; Yoshimoto S; Nibu KI; Homma A; Aoyama H Int J Clin Oncol; 2024 Mar; 29(3):241-247. PubMed ID: 38155239 [TBL] [Abstract][Full Text] [Related]
2. Clinical benefits of combining oral cytotoxic chemotherapeutic agents with radiotherapy in patients with T2N0 glottic squamous cell carcinoma based on the reports of the Head and Neck Cancer Registry of Japan. Ichisaka T; Sano D; Kijima N; Kawakita D; Yoshimoto S; Kitayama M; Nibu KI; Oridate N Oral Oncol; 2024 Oct; 157():106942. PubMed ID: 39029387 [TBL] [Abstract][Full Text] [Related]
3. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base. Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis. Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas. Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345 [TBL] [Abstract][Full Text] [Related]
6. Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer. Beckham TH; Barney C; Healy E; Wolfe AR; Branstetter A; Yaney A; Riaz N; McBride SM; Tsai CJ; Kang J; Yu Y; Chen L; Sherman E; Dunn L; Pfister DG; Tan J; Rupert R; Bonomi M; Zhang Z; Lobaugh SM; Grecula JC; Mitchell DL; Wobb JL; Miller ED; Blakaj DM; Diavolitsis VM; Lee N; Bhatt AD Int J Cancer; 2020 Jul; 147(1):107-115. PubMed ID: 31609479 [TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial. Hitt R; Iglesias L; López-Pousa A; Berrocal-Jaime A; Grau JJ; García-Girón C; Martínez-Trufero J; Guix M; Lambea-Sorrosal J; Del Barco-Morillo E; León-Vintró X; Cunquero-Tomas AJ; Baste N; Ocaña A; Cruz-Hernández JJ; Clin Transl Oncol; 2021 Apr; 23(4):764-772. PubMed ID: 32797376 [TBL] [Abstract][Full Text] [Related]
8. Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer. Cohen EE; Karrison TG; Kocherginsky M; Mueller J; Egan R; Huang CH; Brockstein BE; Agulnik MB; Mittal BB; Yunus F; Samant S; Raez LE; Mehra R; Kumar P; Ondrey F; Marchand P; Braegas B; Seiwert TY; Villaflor VM; Haraf DJ; Vokes EE J Clin Oncol; 2014 Sep; 32(25):2735-43. PubMed ID: 25049329 [TBL] [Abstract][Full Text] [Related]
9. [Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)]. Tahara M Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():167-71. PubMed ID: 16897996 [TBL] [Abstract][Full Text] [Related]
10. Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experience. Ock CY; Keam B; Lim Y; Kim TM; Lee SH; Kwon SK; Hah JH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS Head Neck; 2016 Feb; 38(2):277-84. PubMed ID: 26104823 [TBL] [Abstract][Full Text] [Related]
11. Phase III randomized trial of preoperative concurrent chemoradiotherapy versus preoperative radiotherapy for patients with locally advanced head and neck squamous cell carcinoma. Yi J; Huang X; Xu Z; Liu S; Wang X; He X; Luo D; Luo J; Xiao J; Zhang S; Wang K; Qu Y; Tang Y; Liu W; Xu G; Gao L; Wang D Oncotarget; 2017 Jul; 8(27):44842-44850. PubMed ID: 28179586 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel, cisplatin and 5-fluorouracil induction chemotherapy followed by chemoradiotherapy or chemoradiotherapy alone in stage III-IV unresectable head and neck cancer: Results of a randomized phase II study. Takácsi-Nagy Z; Hitre E; Remenár É; Oberna F; Polgár C; Major T; Gödény M; Fodor J; Kásler M Strahlenther Onkol; 2015 Aug; 191(8):635-41. PubMed ID: 25782685 [TBL] [Abstract][Full Text] [Related]
13. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials. Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693 [TBL] [Abstract][Full Text] [Related]
14. Definitive radiation with concurrent cetuximab vs. radiation with or without concurrent cytotoxic chemotherapy in older patients with squamous cell carcinoma of the head and neck: Analysis of the SEER-medicare linked database. Zandberg DP; Cullen K; Bentzen SM; Goloubeva OG Oral Oncol; 2018 Nov; 86():132-140. PubMed ID: 30409293 [TBL] [Abstract][Full Text] [Related]
15. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651 [TBL] [Abstract][Full Text] [Related]
16. Is definitive concurrent chemoradiotherapy effective for locally advanced head and neck cancer in the elderly aged ≥ 75 years: A single-institute, retrospective, cohort study. Lai KM; Lin JT; Lu HJ; Liang CC; Chen MK Asia Pac J Clin Oncol; 2018 Jun; 14(3):247-255. PubMed ID: 28840980 [TBL] [Abstract][Full Text] [Related]
17. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma. Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin. Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341 [TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. Brizel DM; Esclamado R J Clin Oncol; 2006 Jun; 24(17):2612-7. PubMed ID: 16763273 [TBL] [Abstract][Full Text] [Related]
20. The role of chemotherapy in locally advanced head and neck squamous cell carcinoma. Nwizu T; Ghi MG; Cohen EE; Paccagnella A Semin Radiat Oncol; 2012 Jul; 22(3):198-206. PubMed ID: 22687944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]